Dr. David I. Astrachan, MD

Dr. Astrachan practices at Endoscopy Center of Connecticut in Hamden, Connecticut.

Dr. Astrachan's NPI, 1225009046, was assigned on January 30, 2006. Dr. Astrachan graduated from Yale School of Medicine in 1984. Dr. Astrachan holds Connecticut license 027670.

Dr. Astrachan's primary practice is Endoscopy Center of Connecticut, at 2200 Whitney Avenue, Suite 380, Hamden, CT 06518. The practice phone is (203) 281-3636.

Dr. Astrachan's primary practice is Endoscopy Center of Connecticut in Hamden, Connecticut. Dr. Astrachan is also affiliated with Yale New Haven Hospital. The medical group on file is Northeast Medical Group. Dmand AI also links Dr. Astrachan to 1 more hospital, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Astrachan practices, 5 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Astrachan's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Astrachan is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dr. Astrachan is licensed in Connecticut.

Dmand AI lists acute sinusitis, chronic ear infection, chronic nasal allergies, chronic sinusitis, ear eustachian tube disorders, endoscopic sinus surgery, hearing loss and impairment and larynx and vocal cord disease among the conditions Dr. Astrachan treats.

CMS data shows 2,296 Medicare services from Dr. Astrachan across 13 procedure codes in 2024, for 601 Medicare patients. Medicare paid $113,740 for them. Every service was in an office.

CMS counts 601 Medicare patients who saw Dr. Astrachan in 2024. The largest group is 75 to 84, with 238 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 15% are also on Medicaid. Their average risk score is 1.20, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Astrachan's median patient age at 71, with 52% women.

In 2024, Dr. Astrachan wrote 1,650 Medicare Part D claims for 519 patients. 97% of them were for generic drugs. CMS names the drug for 1,417 of them, across 27 drugs with 11 or more claims each, at $21,065 in total drug cost. In 2023, CMS named 1,213 claims across 25 drugs.

Dr. Astrachan accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 13 papers to Dr. Astrachan. The most frequent topics are Reflex, Startle, Acoustic Stimulation and Electroshock. Dr. Astrachan has published most often in Laryngoscope. Dr. Astrachan's most frequent co-author is W Jarrard Goodwin, MD.

CMS Open Payments shows 107 general payments to Dr. Astrachan from 15 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. GlaxoSmithKline, LLC. paid the most, $673.

Dmand AI lists 3 awards for Dr. Astrachan, most recently Top Doctor Connecticut in 2024.

Dr. Astrachan graduated from Yale School of Medicine in 1984. Dr. Astrachan is a member of NHS.

Dr. Astrachan is in network with 17 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.